-
Something wrong with this record ?
Successful treatment of Keratitis caused by Mycobacterium chelonae and an overview of previous cases in Europe
R. Kukla, K. Nouzovska, L. Ryskova, P. Rozsivalova, I. Pavlik, P. Bostik
Language English Country England, Great Britain
Document type Case Reports, Journal Article, Review
Grant support
MH-CZ DRO (UHHK, 00179906)
Ministerstvo Zdravotnictví Ceské Republiky
MH-CZ DRO (UHHK, 00179906)
Ministerstvo Zdravotnictví Ceské Republiky
MH-CZ DRO (UHHK, 00179906)
Ministerstvo Zdravotnictví Ceské Republiky
MH-CZ DRO (UHHK, 00179906)
Ministerstvo Zdravotnictví Ceské Republiky
NU20-09-00114
Agentura Pro Zdravotnický Výzkum České Republiky
NU20-09-00114
Agentura Pro Zdravotnický Výzkum České Republiky
NLK
BioMedCentral
from 2002-01-01
BioMedCentral Open Access
from 2002
Directory of Open Access Journals
from 2002
Free Medical Journals
from 2002
PubMed Central
from 2002
Europe PubMed Central
from 2002
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2002-01-01
Open Access Digital Library
from 2002-01-01
Open Access Digital Library
from 2002-09-01
Medline Complete (EBSCOhost)
from 2002-09-16
Health & Medicine (ProQuest)
from 2009-01-01
Public Health Database (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2002
Springer Nature OA/Free Journals
from 2002-01-01
- MeSH
- Amikacin therapeutic use MeSH
- Anti-Bacterial Agents * therapeutic use MeSH
- Mycobacterium Infections, Nontuberculous * diagnosis drug therapy microbiology surgery MeSH
- Fluoroquinolones therapeutic use MeSH
- Keratitis * diagnosis drug therapy microbiology surgery MeSH
- Clarithromycin therapeutic use MeSH
- Humans MeSH
- Moxifloxacin * therapeutic use MeSH
- Mycobacterium chelonae * isolation & purification MeSH
- Aged MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Review MeSH
- Geographicals
- Europe MeSH
INTRODUCTION AND PURPOSE: Mycobacterium (M.) chelonae is responsible for a half of relatively rare nontuberculous mycobacteria (NTM) keratitis. We report a case of M. chelonae keratitis in a woman following sclerocorneal suture extraction after cataract surgery. RESULTS: A 70-year-old woman presented with a red eye and corneal infiltration of her left eye six weeks following sclerocorneal suture extraction after an elective cataract surgery in another institute. She complained of a sharp, cutting pain and photophobia. Since initial corneal scrapes and conjunctival swabs proved no pathogen using culture and PCR methods, non-specific antibiotics and antifungal agents were administered. As keratitis was complicated by an inflammation in the anterior chamber and vitreous, samples of the vitreous fluid were sent for microbiologic examination. DNA of Epstein-Barr virus (EBV) was repeatedly detected. Since the intrastromal abscess had formed, corneal re-scrapings were performed and M. chelonae was detected using culture, MALDI-TOF MS and PCR methods. Therapy was changed to a combination of oral and topical clarithromycin, intravitreal, topical and intracameral amikacin, and oral and topical moxifloxacin. The successful therapy led to stabilization. The optical penetrating keratoplasty was performed and no signs of the infection recurrence were found. CONCLUSIONS: The diagnosis of nontuberculous mycobacterial keratitis is difficult and often delayed. An aggressive and prolonged antimicrobial therapy should include systemic and topical antibiotics. Surgical intervention in the form of corneal transplantation may be required in the active and nonresponsive infection. In the presented case this was necessary for visual rehabilitation due to scarring.
Department of Ophthalmology University Hospital Sokolska 581 Hradec Kralove 50005 Czech Republic
Hospital Pharmacy University Hospital Sokolska 581 Hradec Kralove 50005 Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25003912
- 003
- CZ-PrNML
- 005
- 20250206104801.0
- 007
- ta
- 008
- 250121s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12941-024-00752-w $2 doi
- 035 __
- $a (PubMed)39385246
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Kukla, Rudolf $u Institute of Clinical Microbiology, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic $u Institute of Clinical Microbiology, University Hospital, Sokolska 581, Hradec Kralove, 50005, Czech Republic
- 245 10
- $a Successful treatment of Keratitis caused by Mycobacterium chelonae and an overview of previous cases in Europe / $c R. Kukla, K. Nouzovska, L. Ryskova, P. Rozsivalova, I. Pavlik, P. Bostik
- 520 9_
- $a INTRODUCTION AND PURPOSE: Mycobacterium (M.) chelonae is responsible for a half of relatively rare nontuberculous mycobacteria (NTM) keratitis. We report a case of M. chelonae keratitis in a woman following sclerocorneal suture extraction after cataract surgery. RESULTS: A 70-year-old woman presented with a red eye and corneal infiltration of her left eye six weeks following sclerocorneal suture extraction after an elective cataract surgery in another institute. She complained of a sharp, cutting pain and photophobia. Since initial corneal scrapes and conjunctival swabs proved no pathogen using culture and PCR methods, non-specific antibiotics and antifungal agents were administered. As keratitis was complicated by an inflammation in the anterior chamber and vitreous, samples of the vitreous fluid were sent for microbiologic examination. DNA of Epstein-Barr virus (EBV) was repeatedly detected. Since the intrastromal abscess had formed, corneal re-scrapings were performed and M. chelonae was detected using culture, MALDI-TOF MS and PCR methods. Therapy was changed to a combination of oral and topical clarithromycin, intravitreal, topical and intracameral amikacin, and oral and topical moxifloxacin. The successful therapy led to stabilization. The optical penetrating keratoplasty was performed and no signs of the infection recurrence were found. CONCLUSIONS: The diagnosis of nontuberculous mycobacterial keratitis is difficult and often delayed. An aggressive and prolonged antimicrobial therapy should include systemic and topical antibiotics. Surgical intervention in the form of corneal transplantation may be required in the active and nonresponsive infection. In the presented case this was necessary for visual rehabilitation due to scarring.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a amikacin $x terapeutické užití $7 D000583
- 650 12
- $a antibakteriální látky $x terapeutické užití $7 D000900
- 650 _2
- $a klarithromycin $x terapeutické užití $7 D017291
- 650 _2
- $a fluorochinolony $x terapeutické užití $7 D024841
- 650 12
- $a keratitida $x diagnóza $x farmakoterapie $x mikrobiologie $x chirurgie $7 D007634
- 650 12
- $a moxifloxacin $x terapeutické užití $7 D000077266
- 650 12
- $a Mycobacterium chelonae $x izolace a purifikace $7 D016926
- 650 12
- $a atypické mykobakteriální infekce $x diagnóza $x farmakoterapie $x mikrobiologie $x chirurgie $7 D009165
- 650 _2
- $a výsledek terapie $7 D016896
- 651 _2
- $a Evropa $7 D005060
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Nouzovska, Katerina $u Department of Ophthalmology, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic $u Department of Ophthalmology, University Hospital, Sokolska 581, Hradec Kralove, 50005, Czech Republic
- 700 1_
- $a Ryskova, Lenka $u Institute of Clinical Microbiology, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic $u Institute of Clinical Microbiology, University Hospital, Sokolska 581, Hradec Kralove, 50005, Czech Republic
- 700 1_
- $a Rozsivalova, Petra $u Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic $u Hospital Pharmacy, University Hospital, Sokolska 581, Hradec Kralove, 50005, Czech Republic
- 700 1_
- $a Pavlik, Ivo $u Faculty of Regional Development and International Studies, Mendel University in Brno, tr. Generala Piky 7, Brno, 61300, Czech Republic
- 700 1_
- $a Bostik, Pavel $u Institute of Clinical Microbiology, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic. pavel.bostik@lfhk.cuni.cz $u Institute of Clinical Microbiology, University Hospital, Sokolska 581, Hradec Kralove, 50005, Czech Republic. pavel.bostik@lfhk.cuni.cz $1 https://orcid.org/0000000326916458
- 773 0_
- $w MED00008163 $t Annals of clinical microbiology and antimicrobials $x 1476-0711 $g Roč. 23, č. 1 (2024), s. 92
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39385246 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206104756 $b ABA008
- 999 __
- $a ok $b bmc $g 2263578 $s 1239919
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 23 $c 1 $d 92 $e 20241009 $i 1476-0711 $m Annals of clinical microbiology and antimicrobials $n Ann Clin Microbiol Antimicrob $x MED00008163
- GRA __
- $a MH-CZ DRO (UHHK, 00179906) $p Ministerstvo Zdravotnictví Ceské Republiky
- GRA __
- $a MH-CZ DRO (UHHK, 00179906) $p Ministerstvo Zdravotnictví Ceské Republiky
- GRA __
- $a MH-CZ DRO (UHHK, 00179906) $p Ministerstvo Zdravotnictví Ceské Republiky
- GRA __
- $a MH-CZ DRO (UHHK, 00179906) $p Ministerstvo Zdravotnictví Ceské Republiky
- GRA __
- $a NU20-09-00114 $p Agentura Pro Zdravotnický Výzkum České Republiky
- GRA __
- $a NU20-09-00114 $p Agentura Pro Zdravotnický Výzkum České Republiky
- LZP __
- $a Pubmed-20250121